SecSonar.com

Waters Corporation (WAT)

Waters Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Waters Corporation (WAT) is a Medical - Diagnostics & Research company based in US with a market capitalization of $25B. Revenue grew 7.0% year-over-year and the company generated $539.8M in free cash flow. This page tracks WAT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 7.6K employees · IPO Nov 17, 1995

Valuation

Valuation & price

$329.22 · as of May 17, 2026 · -20.2% vs 52w high

30.6

P/E ratio

Latest-FY diluted EPS

9.77

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$413$345$278Jul 25Dec 25Jul 26Jul 7, 25$346.73Jul 9, 25$349.21Jul 11, 25$352.91Jul 15, 25$289.56Jul 17, 25$296.92Jul 21, 25$281.66Jul 23, 25$295.63Jul 25, 25$302.95Jul 29, 25$303.19Jul 31, 25$288.76Aug 4, 25$285.59Aug 6, 25$277.72Aug 11, 25$279.29Aug 13, 25$296.83Aug 15, 25$291.55Aug 19, 25$297.72Aug 21, 25$290.44Aug 25, 25$298.95Aug 27, 25$294.63Aug 29, 25$301.80Sep 3, 25$290.06Sep 5, 25$306.32Sep 9, 25$300.52Sep 11, 25$302.45Sep 16, 25$303.08Sep 18, 25$306.38Sep 22, 25$302.48Sep 24, 25$292.65Sep 26, 25$291.71Sep 30, 25$299.81Oct 2, 25$321.92Oct 6, 25$327.62Oct 8, 25$327.65Oct 10, 25$331.00Oct 14, 25$333.14Oct 16, 25$334.87Oct 21, 25$349.23Oct 23, 25$355.68Oct 27, 25$351.75Oct 29, 25$343.47Oct 31, 25$349.60Nov 4, 25$367.34Nov 6, 25$371.16Nov 10, 25$376.57Nov 12, 25$387.37Nov 14, 25$379.40Nov 18, 25$376.63Nov 20, 25$378.62Nov 25, 25$412.54Nov 28, 25$403.42Dec 2, 25$398.62Dec 4, 25$396.37Dec 8, 25$392.75Dec 10, 25$395.82Dec 12, 25$385.33Dec 16, 25$378.53Dec 18, 25$376.31Dec 22, 25$384.14Dec 24, 25$384.83Dec 29, 25$385.10Jan 2, 26$381.96Jan 6, 26$400.54Jan 8, 26$396.65Jan 12, 26$393.68Jan 14, 26$393.20Jan 16, 26$387.37Jan 21, 26$396.71Jan 23, 26$392.31Jan 27, 26$390.09Jan 29, 26$375.18Feb 2, 26$379.31Feb 4, 26$384.33Feb 9, 26$328.14Feb 11, 26$329.21Feb 13, 26$323.37Feb 18, 26$327.53Feb 20, 26$333.33Feb 24, 26$326.30Feb 26, 26$322.83Mar 2, 26$307.23Mar 4, 26$319.04Mar 6, 26$302.54Mar 10, 26$299.63Mar 12, 26$283.32Mar 17, 26$296.99Mar 19, 26$299.57Mar 23, 26$301.81Mar 25, 26$302.32Mar 27, 26$289.16Mar 31, 26$297.80Apr 2, 26$304.24Apr 7, 26$307.38Apr 9, 26$317.65Apr 13, 26$324.68Apr 15, 26$326.20Apr 17, 26$327.77Apr 22, 26$334.38Apr 24, 26$309.87Apr 28, 26$300.73Apr 30, 26$309.23May 4, 26$301.88May 6, 26$349.53May 8, 26$355.13May 12, 26$352.21May 14, 26$333.21May 18, 26$332.19May 20, 26$341.32May 22, 26$342.37May 28, 26$366.67Jun 1, 26$378.16Jun 3, 26$379.77Jun 5, 26$365.36Jun 9, 26$371.15Jun 11, 26$359.74Jun 15, 26$357.76Jun 17, 26$357.00Jun 22, 26$358.25Jun 24, 26$369.18Jun 26, 26$374.41Jul 2, 26$379.29
$277.7252-week range$412.54
Loading valuation history…

Fundamentals

Key fundamentals

$25B

Market cap

7.0%

Revenue growth (YoY)

57.8%

Gross margin

$539.8M

Free cash flow (USD)

$903.3M

Net debt

0.3%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$2.2BFY 2017$2.3BFY 2018$2.4BFY 2019$2.4BFY 2020$2.4BFY 2021$2.8BFY 2022$3.0BFY 2023$3.0BFY 2024$3.0BFY 2025$3.2B
$2.2B$3.2B

Free cash flow by year

2016 → 2025

FY 2016$534.1MFY 2017$607.2MFY 2018$476.9MFY 2019$479.3MFY 2020$618.1MFY 2021$579.0MFY 2022$428.2MFY 2023$442.2MFY 2024$619.6MFY 2025$539.8M
$534.1M$539.8M

Gross margin by year

2021 → 2025

FY 202158.5%FY 202258.0%FY 202359.6%FY 202459.4%FY 202557.8%
58.5%57.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsMay 22, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing

Questions

Frequently asked questions

What is Waters Corporation's market cap?

Waters Corporation (WAT) has a market capitalization of $25B.

What is WAT's P/E ratio?

WAT trades at a price-to-earnings ratio of 30.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is WAT's price-to-book (P/B) ratio?

WAT trades at 9.77 times book value per share.

Are insiders buying WAT stock?

SEC Form 4 filings show no open-market insider buys at Waters Corporation in the last 90 days (0 sells).

Same arena

Related companies in Medical - Diagnostics & Research

ILMN

Illumina, Inc.

$25B

MTD

Mettler-Toledo International Inc.

$23.8B

DGX

Quest Diagnostics Incorporated

$21.6B

LH

Labcorp Holdings Inc.

$21.5B

IQV

IQVIA Holdings Inc.

$30.5B

NTRA

Natera, Inc.

$31.7B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.